ODI Pharma AB Statistics

Total Valuation

ODI Pharma AB has a market cap or net worth of SEK 31.83 million. The enterprise value is 26.47 million.

Market Cap	31.83M
Enterprise Value	26.47M

Important Dates

The last earnings date was Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

ODI Pharma AB has 15.92 million shares outstanding. The number of shares has increased by 2.64% in one year.

Current Share Class	15.92M
Shares Outstanding	15.92M
Shares Change (YoY)	+2.64%
Shares Change (QoQ)	+2.23%
Owned by Insiders (%)	91.56%
Owned by Institutions (%)	n/a
Float	1.34M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.01
PB Ratio	37.72
P/TBV Ratio	37.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.74
EV / Sales	2.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.13

Current Ratio	1.13
Quick Ratio	1.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.57

Financial Efficiency

Return on equity (ROE) is -257.80% and return on invested capital (ROIC) is -135.61%.

Return on Equity (ROE)	-257.80%
Return on Assets (ROA)	-25.73%
Return on Invested Capital (ROIC)	-135.61%
Return on Capital Employed (ROCE)	-557.10%
Revenue Per Employee	10.57M
Profits Per Employee	-5.59M
Employee Count	1
Asset Turnover	0.93
Inventory Turnover	n/a

Taxes

In the past 12 months, ODI Pharma AB has paid 96,647 in taxes.

Income Tax	96,647
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.87% in the last 52 weeks. The beta is 0.53, so ODI Pharma AB's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	-76.87%
50-Day Moving Average	2.36
200-Day Moving Average	3.43
Relative Strength Index (RSI)	46.89
Average Volume (20 Days)	5,247

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ODI Pharma AB had revenue of SEK 10.57 million and -5.59 million in losses. Loss per share was -0.35.

Revenue	10.57M
Gross Profit	2.33M
Operating Income	-4.70M
Pretax Income	-5.49M
Net Income	-5.59M
EBITDA	-4.70M
EBIT	-4.70M
Loss Per Share	-0.35

Full Income Statement

Balance Sheet

The company has 2.00 million in cash and n/a in debt, giving a net cash position of 2.00 million or 0.13 per share.

Cash & Cash Equivalents	2.00M
Total Debt	n/a
Net Cash	2.00M
Net Cash Per Share	0.13
Equity (Book Value)	843,827
Book Value Per Share	0.05
Working Capital	838,750

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.67M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 22.01%, with operating and profit margins of -44.46% and -52.82%.

Gross Margin	22.01%
Operating Margin	-44.46%
Pretax Margin	-51.91%
Profit Margin	-52.82%
EBITDA Margin	-44.44%
EBIT Margin	-44.46%
FCF Margin	n/a

Dividends & Yields

ODI Pharma AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.64%
Shareholder Yield	n/a
Earnings Yield	-17.55%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1